Evidence map›Paper›PMID 37427010›Full record

SynthesisClinical interventions in aging2023

Prevalence of Sarcopenia in Africa: A Systematic Review.

Bryan Vincent Mballa Yene, Sang-Yeob Lee, Ki-Soo Park, Yang Jae Kang, Sung Hyo Seo, Jun-Il Yoo

Abstract readSystematic Review
In one paragraph

Synthesis in Clinical interventions in aging, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Rural-urban differences in osteoporosis and sarcopenia prevalence among Gambian older adults: a pilot study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Epidemiology of sarcopenia: A narrative review.Osteoporosis and sarcopenia · 2025
    Review
  8. Review
  9. Review
  10. Sarcopenia.Nature reviews. Disease primers · 2024
    Review
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Bryan Vincent Mballa YeneDepartment of Bio & Medical Big Data, Gyeongsang National University Hospital, Jinju, South Korea.ORCID 0000-0001-9819-965X
Sang-Yeob LeeDepartment of Biomedical Research Institute, Gyeongsang National University Hospital, Jinju, South Korea.
Ki-Soo ParkDepartment of Preventive Medicine, School of Medicine, Gyeongsang National University, Jinju, South Korea.ORCID 0000-0001-5571-3639
Yang Jae KangDivision of Life Science Department, Gyeongsang National University, Jinju, South Korea.
Sung Hyo SeoDepartment of Biomedical Research Institute, Gyeongsang National University Hospital, Jinju, South Korea.ORCID 0000-0003-3327-5425
Jun-Il YooDepartment of Orthopaedic Surgery, Inha University Hospital, Incheon, South Korea.ORCID 0000-0002-3575-4123

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: The world population gradually getting older, age-related sarcopenia is becoming more frequent. Known to be highly prevalent in high income countries, relative data in Africa are still scarce. This review aims to estimate the prevalence of sarcopenia in Africa and its characteristics. Study Design and Setting: A literature search in PubMed, Web of Science, Google Scholar, and Scopus was conducted in October 2022. All studies reporting the prevalence of sarcopenia in Africa within 15 years were included, and we did an assessment of bias with Hoy et al's risk bias assessment tool. The estimated prevalence of sarcopenia was the outcome and we performed secondary analyses by age, gender, and diagnostic criteria. The random effect model was used for the prevalence estimation. The prevalence of sarcopenia and 95% confidence interval (95% CI) were calculated using the inverse-variance method. Results: A total of 17 studies met our eligibility criteria, for a study population of 12,690 participants with 44.3% males and 55.7% females. The overall prevalence of sarcopenia was 25% (95% CI: 19-30%). The prevalence of sarcopenia among 50 years old and older was 23% (95% CI: 17-29%). We had a higher prevalence of sarcopenia among males (30%, %95 IC: 20-39%) than females (29%, %95 IC: 21-36%). The prevalence of sarcopenia was different depending on the diagnosis criteria used. Conclusion: The prevalence of sarcopenia in Africa was relatively high. However, the fact that the majority of included studies were hospital-based studies shows the necessity of further community-based studies in order to have a more accurate representation of the situation in the general population.

Indexed as

SarcopeniaAfricaFemaleHumansMalePrevalenceAfricameta-analysisprevalencesarcopenia

Identifiers

PMID37427010
PMCPMC10329476

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.